Editors-in-Chief

Editorial Board

Jean-Pierre Abastado

Singapore, SG

Matthew Albert

Paris, FR

James P. Allison

New York, NY, US

Ron N. Apte

Ben-Gurion University of the Negev
Beer-Sheva, IL

Maha Ayyoub

INSERM
Nantes, FR

Jean-François Bach

Académie des sciences
Paris, FR

Philipp Beckhove

German Cancer Research Center
Heidelberg, DE

Thomas Blankenstein

Max-Delbrück-Centrum
Berlin, DE

Jean-Yves Blay

Lyon, FR

Marc Bonneville

INSERM U892
Nantes, FR

Lisa H. Butterfield

Hillman Cancer Center
Pittsburgh, PA, USA

Anne Caignard

Paris, FR

Xuetao Cao

Chinese Academy of Medical Sciences
Beijing, CN

Chiara Castelli

Istituto Nazionale Tumori
Milano, IT

Federica Cavallo

University of Torino
Torino, IT

Lieping Chen

Yale University
New Haven, CT, US

Aled Clayton

Cardiff, UK

Mario Colombo

Istituto Nazionale Tumori
Milano, IT

Marco Colonna

Washington University School of Medicine
St. Louis, MO, USA

George Coukos

Philadelphia, PA, US

Pierre Coulie

de Duve Institute and Catholic University of Louvain
Louvain, BE

Madhav Dhodapkar

The Rockefeller University
New York, NY, USA

Chen Dong

Houston, TX, US

Glenn Dranoff

Dana-Farber Cancer Institute
Boston, MA, US

Alexander Eggermont

Villejuif, FR

Dean Felsher

Stanford University
Stanford, CA, US

Carl G. Figdor

Nijmegen Centre for Molecular Life Sciences
Nijmegan, NL

Olivera J. Finn

Pittsburgh, PA, US
Web site

Bernard A. Fox

Portland, OR, US

Wolf-Hervé Fridman

Centre de Recherche des Cordeliers
Paris, FR

Dmitry I. Gabrilovich

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL, US

Thomas F. Gajewski

University of Chicago
Chicago, IL, US

Ellie Gilboa

University of Miami
Miami, FL, US

F. Stephen Hodi

Dana-Farber Cancer Institute
Boston, MA, USA

Axel Hoos

New York City, NY, US

Anne Hosmalin

Paris-Descartes University
Paris, FR

Dirk Jaeger

National Center for Tumor Diseases
Heidelberg, DE

Elizabeth M. Jaffee

Baltimore, MD, US

Pawel Kalinski

Pittsburgh, PA, US

Klas Kärre

Karolinska Institute
Stockholm, SE

Rolf Kiessling

Stockholm, SE

Eva Klein

Stockholm, SE

Oliver Lantz

Curie Institute
Paris, FR

Roland Liblau

INSERM UMR1043-CNRS UMR5282-Université Toulouse III
Toulouse, FR

Michael T. Lotze

Pittsburgh, PA, US

Francesco Marincola

Trans-NIH Center for Human Immunology
Bethesda, MD, US

Carlos Martinez-A

Ministry for Science and Innovation
Madrid, ES

Ignacio Melero

University of Navarra
Pamplona, ES

Cornelis J. Melief

University Hospital Leiden
Leiden, NL

Ira Mellman

Genentech Inc.
South San Francisco, CA, US

Lorenzo Moretta

Genova, IT

Sergei A. Nedospasov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Moscow, RU

Hideho Okada

University of Pittsburgh School of Medicine
Pittsburgh, PA, USA

Anna Karolina Palucka

Baylor University Medical Center
Dallas, TX, US

Giorgio Parmiani

San Raffaele Foundation
Milan, IT

Angel Porgador

Beer-Sheva, IL

George Prendergast

Lankenau Institute for Medical Research
Wynnewood, PA, US

Gabriel A. Rabinovich

National Council of Scientific and Technical Research
Buenos Aires, AR

David H. Raulet

University of California, Berkeley
Berkeley, CA, US

Caetano Reis e Sousa

Cancer Research UK
London, UK

Nick Restifo

National Institute of Health
Bethesda, MA, US

Antoni Ribas

Jonsson Comprehensive Cancer Center
Los Angeles, CA, USA

Paola Ricciardi-Castagnoli

Singapore Immunology Network (SIgN)
Singapore, SG

Bruce Robinson

Perth, AU

Pedro Romero

Lausanne, CH

Dolores J. Schendel

Münich, DE

Jeffrey Schlom

National Cancer Institute
Bethesda, MA, US

Hans Schreiber

Chicago, IL, US

Robert Schreiber

Washington University
St. Louis, MO, US

Gerold Schuler

University of Erlangen
Erlangen, DE

Ton Schumacher

Amsterdam, NL

Bruno Silva-Santos

Lisbon, PT

Mark J. Smyth

Melbourne, VIC, AU

Tadatsugu Taniguchi

University of Tokyo
Tokyo, JP

Alain Trautmann

Paris, FR

Giorgio Trinchieri

National Cancer Institute
Frederick, MD, US

Pablo Umana

Glycart Biotechnology AG (Roche Group)
Zurich, C

Danila Valmori

University of Nantes
Nantes, FR

Benoît Van den Eynde

Ludwig Institute for Cancer Research
Brussels, BE
Web site

Pierre Van der Bruggen

Ludwig Institute for Cancer Research
Brussels, BE

Richard Vile

Mayo Clinic
Rochester, MN, US

Eric Vivier

Centre d'Immunologie de Marseille-Luminy (CIML)
Marseille, FR

Hermann Wagner

Technical University Müchen
Munich, DE

Jeffrey Weber

Moffitt Cancer Center
Tampa, FL, USA

Theresa L Whiteside

Pittsburgh, PA, US

Ottmar D. Wiestler

German Cancer Research Center (DKFZ)
Heidelberg, DE

Weiping Zou

Ann Arbor, MI, US